Author:
Masterton Robert,Cornaglia Giuseppe,Courvalin Patrice,Lode Hartmut M.,Rello Jordi,Torres Antoni
Funder
Clinigen Specialty Pharmaceuticals
Subject
Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine
Reference75 articles.
1. EPAR summary for the public. Vibativ, telavancin;European Medicines Agency,2011
2. Hydrophobic vancomycin derivatives with improved ADME properties: discovery of telavancin (TD-6424);Leadbetter;J Antibiot (Tokyo),2004
3. Comparative activity of the new lipoglycopeptide telavancin in the presence and absence of serum against 50 glycopeptide non-susceptible staphylococci and three vancomycin-resistant Staphylococcus aureus;Leuthner;J Antimicrob Chemother,2006
4. Telavancin, a multifunctional lipoglycopeptide, disrupts both cell wall synthesis and cell membrane integrity in methicillin-resistant Staphylococcus aureus;Higgins;Antimicrob Agents Chemother,2005
5. Pharmacodynamics of telavancin (TD-6424), a novel bactericidal agent, against Gram-positive bacteria;Hegde;Antimicrob Agents Chemother,2004
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献